IDEAS Study Reaches Recruitment Goal, Demonstrates Value of PET Scans

  • in news
  • by
  • January 9, 2018
  • Comments Off on IDEAS Study Reaches Recruitment Goal, Demonstrates Value of PET Scans

A swift and accurate diagnosis of Alzheimer’s has a huge impact on access to treatments and eligibility for research trials, plus much-needed support and information services. Yet this diagnosis is often hard to get. An amyloid PET scan provides direct evidence of the amyloid plaques that are hallmarks of Alzheimer’s Continue Reading

INTERIM RESULTS FROM THE IDEAS STUDY REPORTED AT AAIC 2017 IN LONDON

  • in news
  • by
  • July 20, 2017
  • Comments Off on INTERIM RESULTS FROM THE IDEAS STUDY REPORTED AT AAIC 2017 IN LONDON

  CONTACTS: Alzheimer’s Association International Conf. Press Office, +44 (0) 20-7069-6000, media@alz.org Niles Frantz, Alzheimer’s Association, +1 312-365-8782, nfrantz@alz.org   FROM THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2017 ALZHEIMER’S ASSOCIATION LAUNCHES $20 MILLION LIFESTYLE INTERVENTION TRIAL IN THE U.S. TO PREVENT COGNITIVE DECLINE – Results from Nearly 4,000 Participants re: Impact Continue Reading

brain scans

IDEAS Study Spurs Related Research to Impact Dementia Care

  • in news, newsletter
  • by
  • June 15, 2017
  • Comments Off on IDEAS Study Spurs Related Research to Impact Dementia Care

Coordinated Studies Will Become a Powerful Tool for the Alzheimer’s Research Community June 08, 2017 WASHINGTON, DC AND CHICAGO — The milestone Imaging Dementia — Evidence for Amyloid Scanning (IDEAS) Study  is working with government and academic researchers to launch three add-on studies to expand the impact of the core study Continue Reading

IDEAS-Study – Site IRB Closeout Guidance

  • in news
  • by
  • June 7, 2017
  • Comments Off on IDEAS-Study – Site IRB Closeout Guidance

TO:  IDEAS Study Referring Practices As you are aware, the study closed to enrollment on December 6, 2017 with the final PET scans to be conducted by mid-January and all PET assessments/interpretations to be submitted 7 days later.  ACRIN 7155 IDEAS Study will close to data submission on January 31, Continue Reading

IDEAS-Study To Close To Participant Enrollment On December 7

  • in news
  • by
  • June 6, 2017
  • Comments Off on IDEAS-Study To Close To Participant Enrollment On December 7

TO: All IDEAS-Study Site Teams Thanks to your efforts, the IDEAS Study is nearing the study enrollment goal! Therefore, participant enrollment is slated to close on Thursday, December 7. Please see the attached frequently asked questions for details. On behalf of Principal Investigator Gil Rabinovici and the study leadership team, Continue Reading

RoleOfAmyloid

Q&A: IDEAS Study Opens Diagnostic Options for Complicated Dementia Cases

informationBright IDEAS spoke with Constantine Lyketsos, M.D., M.H.S., Elizabeth Plank Althouse Professor for Alzheimer’s Research, director of the Memory and Alzheimer’s Treatment Center and associate director of the Alzheimer’s Disease Research Center, all at Johns Hopkins. The Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Study is an open-label, longitudinal cohort study Continue Reading

IDEAS Study (ACRIN 7155) Amendment 1 Notification – 01.03.2017

  • in newsletter
  • by
  • January 3, 2017
  • Comments Off on IDEAS Study (ACRIN 7155) Amendment 1 Notification – 01.03.2017

TO: IDEAS Study Participating Sites with Central IRB Oversight Please be advised that the IDEAS Study (ACRIN 7155) has recently amended the protocol and informed consents. Please note that the amendment and informed consents relating to the participant and dementia specialist have been approved by the central IRB, Schulman Institutional Continue Reading

IDEAS-Study (ACRIN 7155) Amendment 1 for Local IRB Review – 12.22.2016

  • in newsletter
  • by
  • December 22, 2016
  • Comments Off on IDEAS-Study (ACRIN 7155) Amendment 1 for Local IRB Review – 12.22.2016

TO: IDEAS Study Participating Sites with Local IRB Oversight Please be advised that the IDEAS Study (ACRIN 7155) has recently amended the protocol and informed consents. Please note that the amendment and informed consents relating to the participant and dementia specialist have been approved by the central IRB, Schulman Institutional Continue Reading

IDEAS Study – Aim 2 enrollment on August 1, 2017 – PLEASE READ – 7.26.2017

  • in newsletter
  • by
  • July 27, 2016
  • Comments Off on IDEAS Study – Aim 2 enrollment on August 1, 2017 – PLEASE READ – 7.26.2017

  TO: All IDEAS Study Dementia Specialists and Staff Enrollment of participants needed for Aim 1 of the study will be completed on Monday, July 31, 2017. The 90 day follow up visits and post-PET data collection for these participants will go on per protocol with final data submission anticipated Continue Reading

IDEAS-Study Medicare Claim Denials – Please Let Us Know! – 5.30.2016

  • in newsletter
  • by
  • May 30, 2016
  • Comments Off on IDEAS-Study Medicare Claim Denials – Please Let Us Know! – 5.30.2016

TO:  IDEAS Study PET imaging facility administrators (please forward as needed to coders and billers) The IDEAS Study is aware that a number of Medicare Administrative Contractors (MACs) and Medicare Advantage plans are denying claims for amyloid PET scans performed under the IDEAS Study Coverage with Evidence Development (CED) program.  Continue Reading